354P NUC-3373, a ProTide transformation of 5-FU, in combination with oxaliplatin (NUFOX) or irinotecan (NUFIRI) in patients with advanced colorectal cancer (CRC) (NuTide:302)Andrew L. Coveler, T. R. J. Evans, Kristen K. Ciombor et al.|Annals of Oncology|2022Cited by 3
666P Final results of phase I/II study of NUC-7738 as monotherapy and in combination with pembrolizumab: Anti-tumor immune response in PD-1 inhibitor-resistant patientsSarah P. Blagden, David J. Harrison, S.N. Symeonides et al.|Annals of Oncology|2024Cited by 3